Stealth biotech investments in cancer, diabetes, medicinal mushrooms and stem cell derived cellular vaccines.
Investors 1
| Date | Name | Website |
| 24.06.2022 | Candy Vent... | candyventu... |
Mentions in press and media 1
| Date | Title | Description |
| 16.05.2025 | Intima Bioscience: Data from first-in-human trial targeting CISH in patients with metastatic colorectal cancer | Administered CRISPR genetically engineered CISH-knockout Tumor Infiltrating Lymphocytes as a Model System to Evaluate the Safety and Efficacy of this Classically Undruggable Intracellular Target... |